Silicon Laboratories (NASDAQ:SLAB) Stock Rating Lowered by StockNews.com

Silicon Laboratories (NASDAQ:SLAB) was downgraded by stock analysts at StockNews.com from a “hold” rating to a “sell” rating in a research report issued on Friday.

Several other research analysts also recently weighed in on SLAB. Stifel Nicolaus increased their price target on Silicon Laboratories from $135.00 to $145.00 and gave the stock a “buy” rating in a research note on Monday, January 6th. JPMorgan Chase & Co. cut their target price on Silicon Laboratories from $150.00 to $135.00 and set an “overweight” rating for the company in a research note on Tuesday, November 5th. Barclays raised their target price on Silicon Laboratories from $75.00 to $120.00 and gave the stock an “equal weight” rating in a research note on Friday, January 17th. Morgan Stanley cut their target price on Silicon Laboratories from $123.00 to $97.00 and set an “equal weight” rating for the company in a research note on Tuesday, November 5th. Finally, Needham & Company LLC raised their target price on Silicon Laboratories from $140.00 to $150.00 and gave the stock a “buy” rating in a research note on Wednesday, February 5th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and six have given a buy rating to the company’s stock. According to data from MarketBeat, Silicon Laboratories presently has an average rating of “Hold” and a consensus target price of $136.20.

Silicon Laboratories Trading Down 0.2 %

NASDAQ SLAB opened at $150.44 on Friday. The firm has a market capitalization of $4.88 billion, a P/E ratio of -25.33 and a beta of 1.16. The business has a fifty day simple moving average of $132.69 and a 200 day simple moving average of $118.01. Silicon Laboratories has a 12 month low of $94.00 and a 12 month high of $154.91.

Silicon Laboratories (NASDAQ:SLAB) last announced its earnings results on Tuesday, February 4th. The semiconductor company reported ($0.11) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.11). Silicon Laboratories had a negative return on equity of 10.46% and a negative net margin of 32.69%. The firm had revenue of $166.25 million during the quarter, compared to analyst estimates of $166.09 million. During the same period last year, the firm posted ($1.19) EPS. The business’s revenue was up 91.4% compared to the same quarter last year. As a group, sell-side analysts predict that Silicon Laboratories will post -0.47 EPS for the current fiscal year.

Insider Transactions at Silicon Laboratories

In other Silicon Laboratories news, Director William G. Bock sold 2,000 shares of the business’s stock in a transaction on Wednesday, January 22nd. The shares were sold at an average price of $140.77, for a total transaction of $281,540.00. Following the transaction, the director now owns 32,115 shares in the company, valued at $4,520,828.55. The trade was a 5.86 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Navdeep S. Sooch sold 2,360 shares of the business’s stock in a transaction on Wednesday, February 5th. The shares were sold at an average price of $149.00, for a total transaction of $351,640.00. Following the transaction, the director now owns 400,567 shares in the company, valued at $59,684,483. This trade represents a 0.59 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.72% of the company’s stock.

Institutional Trading of Silicon Laboratories

Large investors have recently made changes to their positions in the stock. Franklin Resources Inc. lifted its stake in Silicon Laboratories by 1.9% in the third quarter. Franklin Resources Inc. now owns 231,889 shares of the semiconductor company’s stock worth $27,001,000 after acquiring an additional 4,278 shares during the period. Point72 Asset Management L.P. purchased a new stake in Silicon Laboratories in the third quarter worth about $7,408,000. Intech Investment Management LLC lifted its stake in Silicon Laboratories by 82.9% in the third quarter. Intech Investment Management LLC now owns 12,837 shares of the semiconductor company’s stock worth $1,484,000 after acquiring an additional 5,818 shares during the period. Barclays PLC lifted its stake in Silicon Laboratories by 23.4% in the third quarter. Barclays PLC now owns 70,568 shares of the semiconductor company’s stock worth $8,157,000 after acquiring an additional 13,363 shares during the period. Finally, Premier Fund Managers Ltd bought a new position in Silicon Laboratories in the third quarter worth about $934,000.

Silicon Laboratories Company Profile

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.